Alnylam Pharmaceuticals reported $401.17M in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 444.8M 96.1M
Agios Pharmaceuticals AGIO:US $ 1207.45M 84.52M
Alnylam Pharmaceuticals ALNY:US $ 401.17M 187.04M
Amgen AMGN:US $ 916M 5784M
Arrowhead Research ARWR:US $ 452.27M 79.71M
Avrobio Inc AVRO:US $ 143.16M 26.31M
Biocryst Pharmaceuticals BCRX:US $ -164.22M 57.23M
Biomarin Pharmaceutical BMRN:US $ 4391.31M 120.58M
Bluebird Bio BLUE:US $ 263.26M 111.02M
Intercept Pharmaceuticals ICPT:US $ -371.76M 187.8M
IONIS PHARMACEUT IONS:US $ 709.57M 62.16M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Moderna Inc MRNA:US 17.08B 2.93B
Neurocrine Biosciences NBIX:US $ 1391.1M 17.1M
Novartis NVS:US $ 61540M 6115M
Ptc Therapeutics PTCT:US $ -90.58M 92.02M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M
Regulus Therapeutics RGLS:US $ 49.24M 5.72M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M
Sarepta Therapeutics SRPT:US $ 856.89M 71.12M
Takeda 4502:JP Y 5683019M 351690M
Ultragenyx Pharmaceutical RARE:US $ 796.42M 126.14M
Vertex Pharmaceuticals VRTX:US $ 10907M 807M
Xencor XNCR:US $ 763.02M 29.52M
YTE INCY:US $ 3863.07M 93.07M